Companies › CING
CINGULATE INC (CING)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001862150 · EDGAR filings · Updated 2026-07-23
CINGULATE INC (CING) has reported institutional ownership of 10.2%, with 27 institutional managers holding positions valued at $7.37M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (1)
- 2026-07-23 — Current report (8-K) filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-20 — Insider transaction reported (Form 4)
- 2026-07-20 — Insider transaction reported (Form 4)
- 2026-07-20 — Insider transaction reported (Form 4)
- 2026-07-20 — Insider transaction reported (Form 4)
- 2026-07-20 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, CINGULATE INC has 27 institutional holders and institutional ownership of 10.2%.
Insider activity
Insiders reported 14 transactions (4 buys, 0 sells) across 6 reporting insiders, with a net reported value of $166.7K.
Data flags from SEC filings
Related companies
Veru Inc (VERU) · MediciNova Inc (MNOV) · BIOHARVEST SCIENCES INC (BHST) · BioXcel Therapeutics Inc (BTAI) · Koninklijke Philips NV (PHG) · NEUPHORIA THERAPEUTICS IN (NEUP)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.